首页 > 最新文献

Revista de gastroenterologia de Mexico (English)最新文献

英文 中文
Hepatitis C virus-positive donors in HCV-negative recipients in liver transplantation: Is it possible in Mexico? 丙型肝炎病毒阳性供体与丙型肝炎病毒阴性受体的肝移植:在墨西哥可行吗?
Pub Date : 2023-10-01 Epub Date: 2023-12-13 DOI: 10.1016/j.rgmxen.2023.08.002
J A Torres-Díaz, E A Jasso-Baltazar, L Toapanta-Yanchapaxi, J Aguirre-Valadez, L Martínez-Matínez, A Sánchez-Cedillo, D Aguirre-Villarreal, I García-Juárez

Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.

丙型肝炎病毒(HCV)感染是一个全球性的公共卫生问题,发病率和死亡率都很高。在肝脏移植方面,器官供不应求,促使人们考虑将 HCV 阳性捐献者的器官用于 HCV 阴性的受者。直接作用抗病毒药物(DAAs)在根除病毒方面已显示出巨大疗效,它的问世使HCV感染供体的器官移植成为可能。本文简要回顾了目前使用 HCV 感染者器官的证据。
{"title":"Hepatitis C virus-positive donors in HCV-negative recipients in liver transplantation: Is it possible in Mexico?","authors":"J A Torres-Díaz, E A Jasso-Baltazar, L Toapanta-Yanchapaxi, J Aguirre-Valadez, L Martínez-Matínez, A Sánchez-Cedillo, D Aguirre-Villarreal, I García-Juárez","doi":"10.1016/j.rgmxen.2023.08.002","DOIUrl":"10.1016/j.rgmxen.2023.08.002","url":null,"abstract":"<p><p>Hepatitis C virus (HCV) infection is a worldwide public health problem associated with significant morbidity and mortality. In the context of liver transplantation, the demand for organs continues to exceed the supply, prompting the consideration of using organs from HCV-positive donors in HCV-negative recipients. The introduction of direct-acting antivirals (DAAs), which have demonstrated great efficacy in eradicating the virus, has made transplantation of organs from donors with HCV infection possible. The present article provides a brief review of the current evidence on the use of organs from HCV-infected patients.</p>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"392-403"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138814820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Mexican consensus on fecal incontinence. 墨西哥关于大便失禁的共识。
Pub Date : 2023-10-01 Epub Date: 2023-12-13 DOI: 10.1016/j.rgmxen.2023.08.003
J M Remes-Troche, E Coss-Adame, K R García-Zermeño, O Gómez-Escudero, M Amieva-Balmori, P C Gómez-Castaños, L Charúa-Guindic, M E Icaza-Chávez, A López-Colombo, E C Morel-Cerda, N Pérez Y López, M C Rodríguez-Leal, N Salgado-Nesme, M T Sánchez-Avila, L R Valdovinos-García, O Vergara-Fernández, A S Villar-Chávez

Fecal incontinence is the involuntary passage or the incapacity to control the release of fecal matter through the anus. It is a condition that significantly impairs quality of life in those that suffer from it, given that it affects body image, self-esteem, and interferes with everyday activities, in turn, favoring social isolation. There are no guidelines or consensus in Mexico on the topic, and so the Asociación Mexicana de Gastroenterología brought together a multidisciplinary group (gastroenterologists, neurogastroenterologists, and surgeons) to carry out the «Mexican consensus on fecal incontinence» and establish useful recommendations for the medical community. The present document presents the formulated recommendations in 35 statements. Fecal incontinence is known to be a frequent entity whose incidence increases as individuals age, but one that is under-recognized. The pathophysiology of incontinence is complex and multifactorial, and in most cases, there is more than one associated risk factor. Even though there is no diagnostic gold standard, the combination of tests that evaluate structure (endoanal ultrasound) and function (anorectal manometry) should be recommended in all cases. Treatment should also be multidisciplinary and general measures and drugs (lidamidine, loperamide) are recommended, as well as non-pharmacologic interventions, such as biofeedback therapy, in selected cases. Likewise, surgical treatment should be offered to selected patients and performed by experts.

大便失禁是指粪便通过肛门时不自主地排出或无法控制排出。大便失禁严重影响患者的生活质量,因为它会影响身体形象和自尊,干扰日常活动,进而导致社会孤立。墨西哥没有关于该主题的指导方针或共识,因此墨西哥肠胃病协会召集了一个多学科小组(肠胃病学家、神经肠胃病学家和外科医生),以达成 "墨西哥关于大便失禁的共识",并为医学界制定有用的建议。本文件通过 35 项声明介绍了所制定的建议。众所周知,大便失禁是一种常见病,其发病率随着年龄的增长而增加,但人们对其认识不足。大便失禁的病理生理学是复杂的、多因素的,在大多数情况下,相关的风险因素不止一个。尽管目前还没有诊断的金标准,但在所有病例中都应建议结合评估结构(肛门内超声)和功能(肛门直肠测压)的检查。治疗也应是多学科的,建议采取一般措施和药物(利多脒、洛哌丁胺),并在选定病例中采取非药物干预措施,如生物反馈疗法。同样,应为特定患者提供手术治疗,并由专家实施。
{"title":"The Mexican consensus on fecal incontinence.","authors":"J M Remes-Troche, E Coss-Adame, K R García-Zermeño, O Gómez-Escudero, M Amieva-Balmori, P C Gómez-Castaños, L Charúa-Guindic, M E Icaza-Chávez, A López-Colombo, E C Morel-Cerda, N Pérez Y López, M C Rodríguez-Leal, N Salgado-Nesme, M T Sánchez-Avila, L R Valdovinos-García, O Vergara-Fernández, A S Villar-Chávez","doi":"10.1016/j.rgmxen.2023.08.003","DOIUrl":"10.1016/j.rgmxen.2023.08.003","url":null,"abstract":"<p><p>Fecal incontinence is the involuntary passage or the incapacity to control the release of fecal matter through the anus. It is a condition that significantly impairs quality of life in those that suffer from it, given that it affects body image, self-esteem, and interferes with everyday activities, in turn, favoring social isolation. There are no guidelines or consensus in Mexico on the topic, and so the Asociación Mexicana de Gastroenterología brought together a multidisciplinary group (gastroenterologists, neurogastroenterologists, and surgeons) to carry out the «Mexican consensus on fecal incontinence» and establish useful recommendations for the medical community. The present document presents the formulated recommendations in 35 statements. Fecal incontinence is known to be a frequent entity whose incidence increases as individuals age, but one that is under-recognized. The pathophysiology of incontinence is complex and multifactorial, and in most cases, there is more than one associated risk factor. Even though there is no diagnostic gold standard, the combination of tests that evaluate structure (endoanal ultrasound) and function (anorectal manometry) should be recommended in all cases. Treatment should also be multidisciplinary and general measures and drugs (lidamidine, loperamide) are recommended, as well as non-pharmacologic interventions, such as biofeedback therapy, in selected cases. Likewise, surgical treatment should be offered to selected patients and performed by experts.</p>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"404-428"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138814763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic bowel obstruction secondary to MALT lymphoma. 继发于 MALT 淋巴瘤的慢性肠梗阻。
Pub Date : 2023-10-01 Epub Date: 2023-12-20 DOI: 10.1016/j.rgmxen.2023.08.007
P I Díaz-Hernández, J G Llanes-Villarreal, U R Valencia Rocha, R M Morales-López, C A Castro-Fuentes
{"title":"Chronic bowel obstruction secondary to MALT lymphoma.","authors":"P I Díaz-Hernández, J G Llanes-Villarreal, U R Valencia Rocha, R M Morales-López, C A Castro-Fuentes","doi":"10.1016/j.rgmxen.2023.08.007","DOIUrl":"10.1016/j.rgmxen.2023.08.007","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"448-450"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138833411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatic infiltration from lobular breast cancer. A rare cause of ascites due to portal hypertension. 小叶乳腺癌的肝浸润。门静脉高压导致腹水的罕见病因。
Pub Date : 2023-10-01 Epub Date: 2023-09-06 DOI: 10.1016/j.rgmxen.2023.07.002
D Muíño-Domínguez, J Martín-Sanz, M Celada-Sendino, G Meijide-Santos, C Álvarez-Navascués
{"title":"Hepatic infiltration from lobular breast cancer. A rare cause of ascites due to portal hypertension.","authors":"D Muíño-Domínguez, J Martín-Sanz, M Celada-Sendino, G Meijide-Santos, C Álvarez-Navascués","doi":"10.1016/j.rgmxen.2023.07.002","DOIUrl":"10.1016/j.rgmxen.2023.07.002","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"441-443"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10243567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact on the incidence of gastrointestinal perforation during the COVID-19 pandemic in the Costa del Sol healthcare system area. COVID-19 大流行期间对太阳海岸医疗系统地区胃肠道穿孔发病率的影响。
Pub Date : 2023-10-01 Epub Date: 2022-06-14 DOI: 10.1016/j.rgmxen.2022.06.008
A M Mudarra Vela, F Rivas Ruiz, J Atienza Carrasco, F J Medina Cano

Introduction and aims: Gastrointestinal perforation is a surgical emergency that is associated with a high mortality rate and requires special care. During the pandemic, there has been competition with COVID-19 patients for health resources, especially ICU bed availability. The primary aim of our study was to compare the incidence of gastrointestinal perforation during the COVID-19 pandemic, with cases registered before the pandemic.

Materials and methods: A retrospective, observational, single center, cohort study was conducted that included patients that underwent emergency surgery for gastrointestinal perforation in the periods during the pandemic (6 months) and before the pandemic (12 months). Sociodemographic characteristics, comorbidities, duration of hospital and ICU stay, status at discharge, and perforation site were compared.

Results: The study included 67 subjects (33 in the pre-pandemic period and 34 in the pandemic period). There were no significant differences regarding sex, age, or comorbidity. The perforation rate per emergency intervention was 4-times higher during the pandemic. There was an increase in the number of patients that were foreigners (4 [11%]) and nonresidents (6 [17%]). ICU admissions decreased (6 [19%]) but ICU stay increased to 137 h. Hospital stay increased by 5 days and delay in care increased 4.5 h. The number of deaths was higher (from 5 [15.2%] to 10 [29.4%]). Four patients with perforations were positive for COVID-19, were admitted to the ICU, and died.

Conclusions: During the COVID-19 pandemic there was an increase in the incidence of gastrointestinal perforations at our healthcare system area; symptoms were more advanced, and mortality was higher.

导言和目的:胃肠道穿孔是一种外科急症,死亡率高,需要特别护理。在流感大流行期间,COVID-19 患者争夺医疗资源,尤其是重症监护室床位。我们研究的主要目的是比较 COVID-19 大流行期间和大流行前登记的胃肠道穿孔病例的发病率:我们进行了一项回顾性、观察性、单中心队列研究,纳入了在大流行期间(6 个月)和大流行前(12 个月)因胃肠道穿孔而接受急诊手术的患者。研究比较了患者的社会人口学特征、合并症、住院时间和重症监护室住院时间、出院时的状况以及穿孔部位:研究包括 67 名受试者(33 名在大流行前,34 名在大流行期间)。性别、年龄或合并症方面没有明显差异。在大流行期间,每次紧急干预的穿孔率要高出 4 倍。外国人(4 [11%])和非本地居民(6 [17%])患者的人数有所增加。入住重症监护室的人数有所减少(6 [19%]),但重症监护室的住院时间增加到 137 小时。四名穿孔患者的 COVID-19 检测呈阳性,他们被送入重症监护室后死亡:结论:在 COVID-19 大流行期间,我们医疗系统所在地区的胃肠道穿孔发病率有所上升;症状更加严重,死亡率更高。
{"title":"Impact on the incidence of gastrointestinal perforation during the COVID-19 pandemic in the Costa del Sol healthcare system area.","authors":"A M Mudarra Vela, F Rivas Ruiz, J Atienza Carrasco, F J Medina Cano","doi":"10.1016/j.rgmxen.2022.06.008","DOIUrl":"10.1016/j.rgmxen.2022.06.008","url":null,"abstract":"<p><strong>Introduction and aims: </strong>Gastrointestinal perforation is a surgical emergency that is associated with a high mortality rate and requires special care. During the pandemic, there has been competition with COVID-19 patients for health resources, especially ICU bed availability. The primary aim of our study was to compare the incidence of gastrointestinal perforation during the COVID-19 pandemic, with cases registered before the pandemic.</p><p><strong>Materials and methods: </strong>A retrospective, observational, single center, cohort study was conducted that included patients that underwent emergency surgery for gastrointestinal perforation in the periods during the pandemic (6 months) and before the pandemic (12 months). Sociodemographic characteristics, comorbidities, duration of hospital and ICU stay, status at discharge, and perforation site were compared.</p><p><strong>Results: </strong>The study included 67 subjects (33 in the pre-pandemic period and 34 in the pandemic period). There were no significant differences regarding sex, age, or comorbidity. The perforation rate per emergency intervention was 4-times higher during the pandemic. There was an increase in the number of patients that were foreigners (4 [11%]) and nonresidents (6 [17%]). ICU admissions decreased (6 [19%]) but ICU stay increased to 137 h. Hospital stay increased by 5 days and delay in care increased 4.5 h. The number of deaths was higher (from 5 [15.2%] to 10 [29.4%]). Four patients with perforations were positive for COVID-19, were admitted to the ICU, and died.</p><p><strong>Conclusions: </strong>During the COVID-19 pandemic there was an increase in the incidence of gastrointestinal perforations at our healthcare system area; symptoms were more advanced, and mortality was higher.</p>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"354-360"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40602183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fecal calprotectin level as a marker of esophageal varices in Egyptian HCV cirrhotic patients. 粪便钙蛋白水平作为埃及丙型肝炎病毒肝硬化患者食管静脉曲张的标志物。
Pub Date : 2023-10-01 Epub Date: 2022-07-06 DOI: 10.1016/j.rgmxen.2022.06.013
D A Header, W I Ellakany, A I Ellakany

Introduction and aim: Esophageal varices are one of the complications of portal hypertension in cirrhotic patients that lead to high morbidity and mortality. Our aim was to assess the fecal calprotectin (FC) level in Egyptian cirrhotic patients as a non-invasive marker for the presence of esophageal varices.

Materials and methods: The current study included 250 participants in the period from June 2019 to November 2020, divided into three groups: group 1: 100 HCV cirrhotic patients with esophageal varices that would then be subdivided, according to the Paquet classification; group 2: 100 HCV cirrhotic patients without esophageal varices; group 3: 50 normal age and sex-matched healthy subjects as the control group. Patients with other causes of abnormal calprotectin results were excluded.

Results: The comparison of FC in the three study groups revealed a statistically significant difference, with FC levels higher in groups 1 and 2 (mean 66.4±10.41 and 48.4±10.92, respectively). There was a significant difference in FC levels between the subgroups, subdivided according to the Paquet classification (P=.001). FC levels were higher in the grade III and IV subgroups. FC in the diagnosis of HCV cirrhotic patients with esophageal varices showed the best performance when the cut-off value was >55; AUC was 0.918, with 92% sensitivity, 95% specificity, and 93% accuracy.

Conclusion: FC levels serve as a screening tool for esophageal varices. FC was higher in cirrhotic patients with esophageal varices, especially in the grade III and IV subgroups, according to the Paquet classification.

简介和目的:食管静脉曲张是肝硬化患者门静脉高压症的并发症之一,可导致高发病率和高死亡率。我们的目的是评估埃及肝硬化患者的粪便钙蛋白(FC)水平,作为食管静脉曲张存在与否的无创标志物:本次研究在2019年6月至2020年11月期间纳入了250名参与者,分为三组:第1组:100名患有食管静脉曲张的HCV肝硬化患者,然后根据Paquet分类法进行细分;第2组:100名无食管静脉曲张的HCV肝硬化患者;第3组:50名年龄和性别匹配的正常健康人作为对照组。排除了因其他原因导致钙蛋白检测结果异常的患者:三个研究组的 FC 比较结果显示,第 1 组和第 2 组的 FC 水平较高(平均值分别为 66.4±10.41 和 48.4±10.92),差异有统计学意义。根据 Paquet 分级细分的亚组之间的 FC 水平存在明显差异(P=.001)。III级和IV级亚组的FC水平更高。FC在诊断伴有食管静脉曲张的HCV肝硬化患者时,当临界值大于55时表现最佳;AUC为0.918,敏感性为92%,特异性为95%,准确性为93%:FC水平可作为食管静脉曲张的筛查工具。结论:根据 Paquet 分级法,肝硬化食管静脉曲张患者的 FC 值较高,尤其是在 III 级和 IV 级亚组中。
{"title":"Fecal calprotectin level as a marker of esophageal varices in Egyptian HCV cirrhotic patients.","authors":"D A Header, W I Ellakany, A I Ellakany","doi":"10.1016/j.rgmxen.2022.06.013","DOIUrl":"10.1016/j.rgmxen.2022.06.013","url":null,"abstract":"<p><strong>Introduction and aim: </strong>Esophageal varices are one of the complications of portal hypertension in cirrhotic patients that lead to high morbidity and mortality. Our aim was to assess the fecal calprotectin (FC) level in Egyptian cirrhotic patients as a non-invasive marker for the presence of esophageal varices.</p><p><strong>Materials and methods: </strong>The current study included 250 participants in the period from June 2019 to November 2020, divided into three groups: group 1: 100 HCV cirrhotic patients with esophageal varices that would then be subdivided, according to the Paquet classification; group 2: 100 HCV cirrhotic patients without esophageal varices; group 3: 50 normal age and sex-matched healthy subjects as the control group. Patients with other causes of abnormal calprotectin results were excluded.</p><p><strong>Results: </strong>The comparison of FC in the three study groups revealed a statistically significant difference, with FC levels higher in groups 1 and 2 (mean 66.4±10.41 and 48.4±10.92, respectively). There was a significant difference in FC levels between the subgroups, subdivided according to the Paquet classification (P=.001). FC levels were higher in the grade III and IV subgroups. FC in the diagnosis of HCV cirrhotic patients with esophageal varices showed the best performance when the cut-off value was >55; AUC was 0.918, with 92% sensitivity, 95% specificity, and 93% accuracy.</p><p><strong>Conclusion: </strong>FC levels serve as a screening tool for esophageal varices. FC was higher in cirrhotic patients with esophageal varices, especially in the grade III and IV subgroups, according to the Paquet classification.</p>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"333-340"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40576777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of audiovisual devices in transnasal endoscopy without sedation to improve tolerance. A prospective clinical trial. 在不使用镇静剂的经鼻内窥镜检查中使用视听设备以提高耐受性。前瞻性临床试验。
Pub Date : 2023-10-01 Epub Date: 2023-01-25 DOI: 10.1016/j.rgmxen.2023.01.004
J A González-González, D E Benavides-Salgado, D Garcia-Compean, B González-Gómez, J M Muñoz-Ayala, R A Jiménez-Castillo, H R Ibarra-Sifuentes, A Atilano-Díaz, J Sordia-Ramírez, M D Ramos-Cuevas, H J Maldonado-Garza

Introduction and aim: Transnasal endoscopy (TNE) has proven its diagnostic utility, but it has not been widely accepted given that it is performed without sedation. There are no previous studies on the use of methods to improve its tolerability. Our aim was to evaluate the tolerability of TNE, when simultaneously performed with an audiovisual device as a distractor.

Methods: We evaluated 50 patients, 10 of whom did not agree to participate. The performance of the procedure was explained, using an audiovisual device. Before randomization, we applied anxiety and depression scores. Patients were divided into 2 groups: Group I (using an audiovisual device during the procedure) and Group II (without a device). Anxiety and numeric pain rating scales were used, and vital signs were monitored and recorded before, during, and after the endoscopy. An overall procedure satisfaction score was applied at the end of the study and 24 h later.

Results: Mean age was 41.6 years and 35 of the patients were women (87.5%). The most frequent indication for TNE was refractory gastroesophageal reflux disease. There were no severe comorbidities, and none of the patients had a significant anxiety or depression score. One patient in Group II did not tolerate TNE due to nasal pain. There was no statistically significant difference between groups, regarding anxiety, pain, vital signs, and satisfaction scale.

Conclusion: Our study showed that TNE was well tolerated and had a high acceptance rate in our patients. The use of distracting audiovisual devices did not increase tolerance to the endoscopic procedure.

简介和目的:经鼻内窥镜检查(TNE)已被证明具有诊断作用,但由于其无需镇静剂,因此尚未被广泛接受。目前还没有关于如何提高其耐受性的研究。我们的目的是评估 TNE 同时使用视听设备分散注意力时的耐受性:我们对 50 名患者进行了评估,其中 10 人不同意参与。我们使用视听设备对手术过程进行了解释。随机分组前,我们对患者进行了焦虑和抑郁评分。患者被分为两组:第一组(手术过程中使用视听设备)和第二组(不使用视听设备)。我们使用了焦虑和数字疼痛评分量表,并在内窥镜检查之前、期间和之后监测和记录了生命体征。在研究结束时和 24 小时后对手术的总体满意度进行评分:平均年龄为 41.6 岁,35 名患者为女性(87.5%)。TNE最常见的适应症是难治性胃食管反流病。患者没有严重的合并症,也没有明显的焦虑或抑郁评分。第二组中有一名患者因鼻腔疼痛而无法忍受 TNE。在焦虑、疼痛、生命体征和满意度量表方面,组间差异无统计学意义:我们的研究表明,患者对 TNE 的耐受性良好,接受率较高。使用分散注意力的视听设备并不会增加患者对内窥镜手术的耐受性。
{"title":"Use of audiovisual devices in transnasal endoscopy without sedation to improve tolerance. A prospective clinical trial.","authors":"J A González-González, D E Benavides-Salgado, D Garcia-Compean, B González-Gómez, J M Muñoz-Ayala, R A Jiménez-Castillo, H R Ibarra-Sifuentes, A Atilano-Díaz, J Sordia-Ramírez, M D Ramos-Cuevas, H J Maldonado-Garza","doi":"10.1016/j.rgmxen.2023.01.004","DOIUrl":"10.1016/j.rgmxen.2023.01.004","url":null,"abstract":"<p><strong>Introduction and aim: </strong>Transnasal endoscopy (TNE) has proven its diagnostic utility, but it has not been widely accepted given that it is performed without sedation. There are no previous studies on the use of methods to improve its tolerability. Our aim was to evaluate the tolerability of TNE, when simultaneously performed with an audiovisual device as a distractor.</p><p><strong>Methods: </strong>We evaluated 50 patients, 10 of whom did not agree to participate. The performance of the procedure was explained, using an audiovisual device. Before randomization, we applied anxiety and depression scores. Patients were divided into 2 groups: Group I (using an audiovisual device during the procedure) and Group II (without a device). Anxiety and numeric pain rating scales were used, and vital signs were monitored and recorded before, during, and after the endoscopy. An overall procedure satisfaction score was applied at the end of the study and 24 h later.</p><p><strong>Results: </strong>Mean age was 41.6 years and 35 of the patients were women (87.5%). The most frequent indication for TNE was refractory gastroesophageal reflux disease. There were no severe comorbidities, and none of the patients had a significant anxiety or depression score. One patient in Group II did not tolerate TNE due to nasal pain. There was no statistically significant difference between groups, regarding anxiety, pain, vital signs, and satisfaction scale.</p><p><strong>Conclusion: </strong>Our study showed that TNE was well tolerated and had a high acceptance rate in our patients. The use of distracting audiovisual devices did not increase tolerance to the endoscopic procedure.</p>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"347-353"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10625604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of bevacizumab in chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. 贝伐单抗在遗传性出血性毛细血管扩张症慢性胃肠道出血中的应用。
Pub Date : 2023-10-01 Epub Date: 2023-10-11 DOI: 10.1016/j.rgmxen.2023.04.015
A Gutiérrez-Macías, I Barroso-Benayos, A Burzako-Sánchez
{"title":"Utility of bevacizumab in chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.","authors":"A Gutiérrez-Macías, I Barroso-Benayos, A Burzako-Sánchez","doi":"10.1016/j.rgmxen.2023.04.015","DOIUrl":"10.1016/j.rgmxen.2023.04.015","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"433-434"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41223008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility of serum ammonia in critically ill hospitalized patients with hepatic encephalopathy. 血清氨在肝性脑病危重住院患者中的应用。
Pub Date : 2023-10-01 Epub Date: 2023-10-11 DOI: 10.1016/j.rgmxen.2023.09.002
M E Phinder-Puente, O R Pérez-Nieto, N N Hernández-Velázquez, T O Mondragón-Labelle, E Deloya-Tomas
{"title":"Utility of serum ammonia in critically ill hospitalized patients with hepatic encephalopathy.","authors":"M E Phinder-Puente, O R Pérez-Nieto, N N Hernández-Velázquez, T O Mondragón-Labelle, E Deloya-Tomas","doi":"10.1016/j.rgmxen.2023.09.002","DOIUrl":"10.1016/j.rgmxen.2023.09.002","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"455-456"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41223009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human intestinal spirochetosis as a cause of chronic diarrhea in an HIV-positive patient: A case report. 人类肠道螺旋体病是HIV阳性患者慢性腹泻的原因:一例病例报告。
Pub Date : 2023-10-01 Epub Date: 2023-10-11 DOI: 10.1016/j.rgmxen.2023.09.001
A J Chaar, J S Arbelaez, M J Vargas, R A Cañadas
{"title":"Human intestinal spirochetosis as a cause of chronic diarrhea in an HIV-positive patient: A case report.","authors":"A J Chaar, J S Arbelaez, M J Vargas, R A Cañadas","doi":"10.1016/j.rgmxen.2023.09.001","DOIUrl":"10.1016/j.rgmxen.2023.09.001","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":" ","pages":"443-446"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41223007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de gastroenterologia de Mexico (English)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1